Certificate of Analysis (COA) View the laboratory certificate for this product [ View COA ]

Pure ARA-290 10mg

R 569.00
Add to WishlistCompare

ARA-290 10mg — Research-Grade Peptide

ARA-290 (Cibinetide) 10mg is a research-grade peptide supplied by Pure Performance Labs as lyophilised material for laboratory and scientific research. ARA-290 is an erythropoietin-derived peptide investigated in research relating to tissue protection, inflammatory signalling and neuroprotective pathways.

This product is supplied strictly for research purposes and is not intended for human or veterinary use.

Research Overview

Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.

ARA-290, also known as Cibinetide, is an erythropoietin-derived peptide studied for its biological activity beyond the classical erythropoietin receptor pathway. Research has examined its interaction with tissue-protective signalling mechanisms and its potential relevance to inflammatory and neurological research.

Research Interest

ARA-290 is investigated in laboratory research involving:

• Tissue-protective signalling
• Inflammatory pathway research
• Neuroprotective research
• Cellular response and recovery studies
• Erythropoietin-derived peptide research

Product Information

• Product: ARA-290 (Cibinetide)
• Quantity: 10mg
• Format: Lyophilised powder
• Supplier: Pure Performance Labs
• Research category: Tissue Repair & Recovery Research
• Intended use: Laboratory research only

Research Context

Researchers investigating ARA-290 may examine its molecular characteristics and biological activity using appropriate laboratory models and analytical methodologies. Research design, experimental conditions and analytical procedures should be determined by appropriately qualified researchers.

Research-Use Notice

ARA-290 10mg is supplied for laboratory and scientific research purposes only. It is not intended for human consumption, self-administration, diagnosis, treatment, prevention or veterinary use.

Key Features

• Research-grade peptide compound
• Investigated in laboratory studies of cellular signalling and biological response pathways
• Suitable for controlled biochemical research
• 10mg research presentation
• Supplied for research purposes only

Dosage & Usage

ARA-290 is an experimental peptide derived from a specific region of erythropoietin (EPO) and has been investigated separately from EPO's erythropoietic activity.

Preclinical research has explored ARA-290 in relation to tissue-protective signalling, inflammatory pathways and cellular responses. Its mechanisms and potential applications remain subjects of ongoing scientific investigation.

Research classification: Peptide research / tissue biology / cellular signalling / inflammatory pathway research.

FAQ's & Tips

FAQ

What is ARA-290?
ARA-290 is an experimental peptide derived from erythropoietin that has been investigated for its biological activity in tissue and cellular research.

What is the reference strength of Pure ARA-290?
The PURE Labs listing specifies a 10 mg reference strength.

What is ARA-290 researched for?
ARA-290 has been investigated in areas including tissue biology, cellular signalling, inflammatory pathways and neurobiology.

What is the amino acid sequence of ARA-290?
The PURE Labs listing gives the sequence as pGlu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-NH2.

Is ARA-290 intended for human use?
No. This product is supplied strictly for laboratory and scientific research and is not intended for human or animal consumption.

Research

ARA-290 is a synthetic peptide derived from the helix-B region of erythropoietin and designed to engage the proposed innate repair receptor rather than the classical erythropoietic EPO receptor. Research has examined tissue-protective and repair-related signalling in experimental models, including pathways relevant to inflammation and nerve or tissue response. The evidence is investigational and should not be presented as established therapy. For laboratory research use only.

Reviews